Dynamics of cytokines (IFNγ, IFNα, IL18, TNFα) in the treatment of intermediate influenza A (H1N1) pdm09 (2013-2016) with Oseltamivir (Tamiflu) and Umifenovir (Arbidol) in monotherapy and in combination with Kagocel

Terapevticheskii Arkhiv

Volumn 89, Issue 10, 2017, Pages 66-70

  Popov, A F ^a   Simakova, A I ^a   Dmitrenko, K A ^a   Shchelkanov, M Yu ^b,c,d  

^a PACIFIC STATE MEDICAL UNIVERSITY   (Russian Federation)

^b FAR EASTERN FEDERAL UNIVERSITY   (Russian Federation)

^c INSTITUTE OF BIOLOGY AND SOIL SCIENCE   (Russian Federation)

^d INSTITUTE OF MARINE BIOLOGY   (Russian Federation)

Author keywords

Arbidol; Combined therapy; Cytokines; Influenza; Kagocel; Monotherapy; Oseltamivir; Tamiflu; Umifenovir

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; ARBIDOL; GAMMA INTERFERON; IMMUNOLOGIC FACTOR; INDOLE DERIVATIVE; INTERLEUKIN 18; OSELTAMIVIR; TUMOR NECROSIS FACTOR;

ADULT; COMBINATION DRUG THERAPY; FEMALE; HUMAN; IMMUNOLOGICAL PROCEDURES; IMMUNOLOGY; INFLUENZA; INFLUENZA A VIRUS (H1N1); ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; PROCEDURES; TREATMENT OUTCOME;

ADULT; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; IMMUNOLOGIC TESTS; INDOLES; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; INTERFERON-ALPHA; INTERFERON-GAMMA; INTERLEUKIN-18; MALE; MIDDLE AGED; OSELTAMIVIR; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85034645323     PISSN: 00403660     EISSN: 23095342     Source Type: Journal    
DOI: 10.17116/terarkh2017891066-70     Document Type: Article

References (20)

1. Pulmonology. National guidance. Ed. Chuchalin AG. Moscow: GEOTAR-Media; 2013:143-170. (In Russ.)].
2. Handbook of Virology. Viruses and viral infections of humans and animals. Ed. Lvov D.K. Moscow: Medical Information Agency; 2013. (In Russ.)].
3. Shchelkanov MYu, Kolobukhina LV, Lvov DK. Influenza: history, clinics, pathogenesis. Lechaschii Vrach (The Practitioner). 2011; (10):33-38. (In Russ.). Available at: https://www.lvrach.ru/2011/10/15435275/ Accessed 12.05.2017.].
4. Influenza: epidemiology, diagnostics, treatment, prophylaxis. Ed.: Kiselev OI, Tsybalova LM, Pokrovsky VI. Moscow: Medical Information Agency; 2012. (In Russ.)].
5. Sominina AA, Grudinin MP, Eropkin MYu, Smorodintseva EA, Pisareva MM, Komissarov AB, Konovalova NI, Danilenko DM, Gudkova TM, Kiselev OI. Development of Influenza Surveillance in Russia in the System of the WHO National Influenza Center. Voprosy Virusologii. 2012; 57(6):17-21. (In Russ.). Available at: http://elibrary.ru/item.asp?id=18752161 Accessed 12.05.2017.]
6. Kolobukhina LV, Merkulova LN, Shchelkanov MYu, Burtseva EI, Lavrishcheva VV, Samokhvalov EI, Alkhovsky SV, Prilipov AG, Proshina ES, Avdeev SN, Sutochnikova OA, Bazarova MV, Kelly EI, Tsurukalova ND, Blank IA, Shestakova OM, Kolivashko ON, Arseneva TV, Ambrosi OE, Shuldyakov AA, Popov AF, Simakova AI, Malyshev NA, Chuchalin AG, Lvov DK. Pandemic influenza in Russia: specific features of clinical course and the absence of early etiotropic therapy as a risk factor of severe forms of the disease. Terapevticheskyi Arkhiv. 2011; 83(9):48-53. (In Russ.)].
7. Shchelkanov MYu, Popov AF, Simakova AI, Zenin IV, Proshina ES, Kirillov IM, Dmitrienko KA, Shevchuk DV. Influenza pathogenesis: mechanisms of modulation by agent proteins. Zhurnal Infektologii. 2015; 7(2):31-46. (In Russ.). Available at: http://journal.niidi.ru/jofin/article/view/395/385 Accessed 12. 05.2017.]
8. Carvajal-Yepes M, Sporer KR, Carter JL, Colvin CJ, Coussens PM. Enhanced production of human influenza virus in PBS-12SF cells with a reduced interferon response. Hum Vaccin Immunother. 2015; 11(9):2296-2304. https://doi.org/10.1080/21645515.2015.1016677
9. Liu G, Park HS, Pyo HM, Liu Q, Zhou Y Influenza A Virus Panhandle Structure Is Directly Involved in RIG-I Activation and Interferon Induction. J Virol. 2015; 89(11):6067-6079. https://doi.org/10.1128/JVI.00232-15
10. Bui M, Myers JE, Whittaker GR. Nucleo-cytoplasmic localization of influenza virus nucleoprotein depends on cell density and phosphorylation. Virus Res. 2002; 84(1-2):37-44. http://www.sciencedirect.com/science/article/pii/S0168170201004130
11. Li WX, Li H, Lu R, Li F, Dus M, Atkinson P, Brydon EW, Johnson KL, García-Sastre A, Ball LA, Palese P, Ding SW. Interferon antagonist proteins of influenza and vaccinia viruses are suppres-sors of RNA silencing. Proc Natl Acad Sci USA. 2004; 101(5):1350-1355. Available at: http://www.pnas.org/content/101/5/1350.long Accessed 12.05. 2017
12. De Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN, Hoang DM, Chau NV, Khanh TH, Dong VC, Qui PT, Cam BV, Ha do Q, Guan Y, Peiris JS, Chinh NT, Hien TT, Farrar J. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med. 2006; (12):1203-1207. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4333202/pdf/emss-30376.pdf Accessed 12.05.2017.
13. Lvov DK, Shchelkanov MYu, Alkhovsky SV, Deryabin PG. Zoonotic viruses of Northern Eurasia. Taxonomy and Ecology. Academic Press; 2015.
14. Sergeeva IV, Kamzalakova NI, Tikhonova EP, Bulygin GV. Pathogenesis acute respiratory viral infections and influenza. Prakticheskaya Meditcina. 2012; (6):47-50. Available at: http://elibrary.ru/item.asp?id=17952994 Accessed 12.05.2017.]
15. Kolobukhina LV, Merkulova LN, Burtseva EI, Shchelkanov MYu Oseltamivir (Tamiflu): a possibility for highly effective treatment of influenza. Russkii Meditcinskii Zhurnal (Russian Medical Journal). 2008; 16(2):69-73. (In Russ.). Available at: http://elibrary.ru/item.asp?id=22934991 Accessed 12.05.2017.].
16. Teissier E, Zandomeneghi G, Loquet A, Lavillette D, Lavergne JP, Montserret R, Cosset FL, Böckmann A, Meier BH, Penin F, Pecheur EI. Mechanism of inhibition of enveloped virus membrane fusion by the antiviral drug arbidol. PLoS One. 2011; 6(1):e15874. doi:10.1371/journal.pone.0015874
17. Ershov FI, Kiselev OI. Influenza viruses and interferon system. Interferons and their inductors (from the molecule to the cure). Moscow: Meditcina; 2005. (In Russ.)].
18. Vartanyan RV, Sergeeva EM, Cheshik SG. Evaluation of Therapeutic Efficacy of Kagocel® Preparation in Children of Early and Preschool Age with Acute Respiratory Viral Infections. Detskiye Infektcii. 2011; 10(1):36-41. (In Russ.). Available at: http://elibrary.ru/item.asp?id=15841916 Accessed 12.05.2017.]
19. Du G, Ye L, Zhang G, Dong Q, Liu K, Tian J. Human IL18-IL2 fusion protein as a potential antitumor reagent by enhancing NK cell cytotoxicity and IFN-γ production. J Cancer Res Clin Oncol. 2012; 138(10):1727-1736. https://doi.org/10.1007/s00432-012-1248-5
20. Nogueira LG, Frade AF, Ianni BM, Laugier L, Pissetti CW, Cabantous S, Baron M, Peixoto Gde L, Borges A de M, Donadi E, Marin-Neto JA, Schmidt A, Dias F, Saba B, Wang HT, Fragata A, Sampaio M, Hirata MH, Buck P, Mady C, Martinelli M, Lensi M, Siqueira SF, Pereira AC, Rodrigues VJr, Kalil J, Chevillard C, Cunha-Neto E. Functional IL18 polymorphism and susceptibility to Chronic Chagas Disease. Cytokine. 2015; 73(1):79-83. https://doi.org/10.1016/j.cyto.2015.01.037